162 related articles for article (PubMed ID: 1394234)
21. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study.
Pelosi G; Del Curto B; Trubia M; Nicholson AG; Manzotti M; Veronesi G; Spaggiari L; Maisonneuve P; Pasini F; Terzi A; Iannucci A; Viale G
Clin Cancer Res; 2007 Apr; 13(7):1995-2004. PubMed ID: 17404079
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.
Horio Y; Takahashi T; Kuroishi T; Hibi K; Suyama M; Niimi T; Shimokata K; Yamakawa K; Nakamura Y; Ueda R
Cancer Res; 1993 Jan; 53(1):1-4. PubMed ID: 8380124
[TBL] [Abstract][Full Text] [Related]
24. [p53 alterations and chromosome 17 aberrations in non-small cell lung cancer].
Tsuji T; Tagawa Y; Hisamatsu T; Nakamura S; Terada R; Sawai T; Yasutake T; Ayabe H
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():263-8. PubMed ID: 9263513
[TBL] [Abstract][Full Text] [Related]
25. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
26. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
27. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
[TBL] [Abstract][Full Text] [Related]
28. Sequential molecular genetic changes in lung cancer development.
Chung GT; Sundaresan V; Hasleton P; Rudd R; Taylor R; Rabbitts PH
Oncogene; 1995 Dec; 11(12):2591-8. PubMed ID: 8545116
[TBL] [Abstract][Full Text] [Related]
29. Gain of 1q25-32, 12q23-24.3, and 17q12-22 facilitates tumorigenesis and progression of human squamous cell lung cancer.
Ma J; Gao M; Lu Y; Feng X; Zhang J; Lin D; Xiao T; Hu Z; Yuan J; Su K; Shipley J; Xue J; Gao Y
J Pathol; 2006 Oct; 210(2):205-13. PubMed ID: 16927450
[TBL] [Abstract][Full Text] [Related]
30. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
31. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
Sakamoto T; Nomura N; Mori H; Wake N
Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
[TBL] [Abstract][Full Text] [Related]
32. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.
Massenkeil G; Oberhuber H; Hailemariam S; Sulser T; Diener PA; Bannwart F; Schäfer R; Schwarte-Waldhoff I
Anticancer Res; 1994; 14(6B):2785-90. PubMed ID: 7872719
[TBL] [Abstract][Full Text] [Related]
33. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
34. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
[TBL] [Abstract][Full Text] [Related]
35. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
[TBL] [Abstract][Full Text] [Related]
36. Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands.
Van Den Broek MH; Renault B; Fodde R; Verspaget H; Griffioen G; Khan PM
Anticancer Res; 1993; 13(3):587-92. PubMed ID: 8317886
[TBL] [Abstract][Full Text] [Related]
37. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy.
Rugge M; Bovo D; Busatto G; Parenti AR; Fawzy S; Guido M; Ancona E; Ninfo V; Ruol A; Shiao YH
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):171-6. PubMed ID: 9138659
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of p53 gene mutation in esophageal exfoliative cells].
Kou YL; Zhang JR; Zhou Q; Zhao YF; Chen GD
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):349-52. PubMed ID: 15312345
[TBL] [Abstract][Full Text] [Related]
39. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma.
Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Russell SE
Cancer Res; 1995 Aug; 55(15):3406-11. PubMed ID: 7614480
[TBL] [Abstract][Full Text] [Related]
40. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]